Haematologist swims oceans to make a difference
- Media releases
- Our supporters
Author: Michael Yare
Growing concern as blood cancer rates continue to rise
- Media releases
After leukaemia: I look at life through different eyes
Richard was affected by skin GVHD after his transplant for AML.
- Acute myeloid leukaemia
Ibrutinib now cheaper for patients
- Advocacy and policy
- Chronic lymphocytic leukaemia
- Media releases
Improving the “wait and see” approach to treatment for high-risk blood cancer
Researchers have discovered why half of patients with a type of high-risk blood cancer will not respond to a common treatment.
- Myelodysplastic syndromes
- Research
“I needed two transfusions to make my daughter’s wedding”
Des says he owes his life to a clinical trial for the drug venetoclax.
- Chronic lymphocytic leukaemia
Anthony’s grateful family honours his memory with gift
The Leukaemia Foundation has thanked the Mammino and Puglisi families for their incredibly generous $10,000 gift.
- Our supporters
The latest on CAR T-cell therapy research
- Media releases
World-first blood test could provide more effective, less invasive blood cancer treatments
- Media releases
15-year Holden partnership celebrated
- Media releases
- Our supporters
- Support services
- Talking Blood Cancer: Overcoming ALL
- “Live life to the fullest”: Josh Gourlay opens up about returning to work and new beginnings after blood cancer
- Advocacy news – July 2024
- Talking Blood Cancer: Estate planning and medical directives
- Running for a Cause: Cal Gates’ Journey from Newcastle to Sydney on foot in one weekend